Your search returned 187 studies. (Get alerts for new studies):
- Bortezomib in Treating Patients With Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes
1 Location available
- Oral Clofarabine Study in Patients With Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndrome - Chronic Myelomonocytic Leukemia
1 Location available
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leuk
3 Locations available
- Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloprolife
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
Conditions: Chronic Myelogenous Leukemia - Acute Myelogenous Leukemia - Chronic Lymphocytic Leukemia - Acute Lymphoblastic Leukemia - Myelodysplastic Syndrome
1 Location available
- Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases
Conditions: Leukemia - Myelodysplastic Syndromes
24 Locations available
- Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndrome
3 Locations available
- Cord Blood Expansion on Mesenchymal Stem Cells
Conditions: Myelodysplastic Syndrome - Leukemia
1 Location available
- Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Pat
Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute
1 Location available
- A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy
Conditions: Cancer - Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matche
Conditions: Acute Myeloid Leukemia - Advanced Myelodysplastic Syndromes
1 Location available
- Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Trans
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndrome - Acute Lymphocytic Leukemia - Relapsed/Refractory Chronic Lymphocytic Leukemia - Relapsed/Refractory Non Hodgkin's Lymphoma - Hodgkins Disease - Relapsed Refractory Multiple Myeloma
2 Locations available
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Ca
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
5 Locations available
- Chemotherapy Followed by Allogeneic Stem Cell Transplantation in Treating Children With Hematologic Cancer
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
Conditions: Childhood Langerhans Cell Histiocytosis - Fanconi Anemia - Leukemia - Lymphoma - Myelodysplastic Syndromes - Neuroblastoma - Sarcoma - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
Conditions: Kidney Cancer - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Cyclophosphamide, Fludarabine, Total-Body Irradiation, and Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer or Other
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes
1 Location available
- Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer o
Conditions: Graft Versus Host Disease - Leukemia - Myelodysplastic Syndromes
1 Location available
- Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
Conditions: Myelodysplastic Syndrome - Hodgkin's Lymphoma - Non-Hodgkin's Disease - Acute Leukemia - Multiple Myeloma
1 Location available
- Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)
Conditions: Leukemia - Myelodysplastic Syndrome
1 Location available
- Intensity-Modulated Radiation Therapy, Fludarabine, and Melphalan Followed by a Donor Stem Cell Transplant in Treating Patients With Hematological Can
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies
Conditions: Leukemia, Myeloid, Acute - Leukemia, Lymphoid - Myelodysplastic Syndromes - Leukemia, Myelogenous, Chronic
1 Location available
- Anti-CD45 Monoclonal Antibody, Cytarabine, Cyclophosphamide, and Total-Body Irradiation With or Without Alemtuzumab in Treating Patients Undergoing a
Conditions: Leukemia - Myelodysplastic Syndromes
2 Locations available
- Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia (AML) - Myelodysplastic Syndrome (MDS)
1 Location available
- Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndromes - Lymphoma - Multiple Myeloma - Leukemia, Myelomonocytic, Chronic
4 Locations available
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
308 Locations available
- Fludarabine, Melphalan, Total-Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Dis
Conditions: Chronic Myeloproliferative Disorders - Fanconi Anemia - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases - Nonmalignant Neoplasm - Paroxysmal Nocturnal Hemoglobinuria
1 Location available
- 5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Adult Acute Myeloid Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Recurrent Adult Acute Myeloid Leukemia - Secondary Acute Myeloid Leukemia - Secondary Myelodysplastic Syndromes - Untreated Adult Acute Myelo
1 Location available
- Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases - Nonmalignant Neoplasm - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol S
1 Location available
- Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
Conditions: Leukemia - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
140 Locations available
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By an Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in T
Conditions: Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
214 Locations available
- Combination Chemotherapy Followed By Donor Umbilical Cord Blood Transplant in Treating Infants With High-Risk Acute Leukemia or Myelodysplastic Syndro
Conditions: Leukemia - Myelodysplastic Syndromes
1 Location available
- T-cell Recovery in Patients With Leukemia, Advanced Lymphoma, Myelodysplastic Syndrome, or Myeloproliferative Disorder Receiving Alemtuzumab and Under
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes
Conditions: Fatigue - Myelodysplastic Syndromes
2 Locations available
- Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes
1 Location available
- Clofarabine and Cytarabine in Treating Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes That Have Relapsed or Not Res
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) - Adult Acute Myeloid Leukemia With t(8;21)(
1 Location available
- Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
Conditions: Fever, Sweats, and Hot Flashes - Infection - Leukemia - Lymphoma - Myelodysplastic Syndromes - Neutropenia - Unspecified Childhood Solid Tumor, Protocol Specific
3 Locations available
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
154 Locations available
- Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Conditions: Leukemia, Acute Myelogenous (AML) - Leukemia, Acute Lymphocytic (ALL) - Leukemia, Chronic Myelogenous (CML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma (NHL)
1 Location available
- A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndromes - Thrombocytopenia
1 Location available
- A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q
Conditions: Anemia
4 Locations available
- Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) - Adult Acute Myeloid Leukemia With t(16;16)
1 Location available
- Chemotherapy and Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Disease or Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplan
Conditions: Chronic Myeloproliferative Disorders - Kidney Cancer - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Oral Complications - Ovarian Cancer - Pain
1 Location available
- Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Precancerous Condition
1 Location available
- Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Conditions: Kidney Cancer - Leukemia - Lymphoma - Myelodysplastic Syndromes - Neuroblastoma - Pulmonary Complications - Sarcoma
38 Locations available
- PXD101 and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia - Myelodysplastic Syndromes
137 Locations available
- Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Secondary Myelofibrosis - Small Intestine Cance
1 Location available
- Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies
Conditions: Leukemia - Myelodysplastic Syndrome
1 Location available
- Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)
Conditions: Acute Myelocytic Leukemia - Acute Lymphocytic Leukemia - Chronic Myelocytic Leukemia - Chronic Lymphocytic Leukemia - Myelodysplastic Syndromes
1 Location available
- Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
Conditions: Myelodysplastic Syndromes
5 Locations available
- Ondansetron Versus Aprepitant Plus Ondansetron for Emesis
Conditions: Hematologic Diseases - Acute Myelogenous Leukemia - Myelodysplastic Syndrome - Chronic Myelogenous Leukemia
1 Location available
- Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Conditions: Acute Lymphocytic Leukemia - Acute Myeloid Leukemia - Myelodysplastic Syndrome - Chronic Myelogenous Leukemia
1 Location available
- Registry of Older Patients With Cancer
Conditions: Chronic Myeloproliferative Disorders - Cognitive/Functional Effects - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Unspecified A
7 Locations available
- Laboratory-Treated Peripheral Blood Cell Infusion After Donor Stem Cell Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Conditions: Leukemia - Myelodysplastic Syndromes
5 Locations available
- Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndrome - Leukemia
1 Location available
- Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Precancerous Condition - Secondary Myelofibrosis
1 Location available
- A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Autologous or Allogeneic Transplantation for AML, CML, ALL, MDS, an
Conditions: Acute Myelogenous Leukemia (AML) - Chronic Myelogenous Leukemia (CML) - Acute Lymphoblastic Leukemia (ALL) - Myelodysplastic Syndrome (MDS) - B Cell Malignancies
1 Location available
- Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC
Conditions: MonoMAC - Myelodysplastic Syndrome - Immunodeficiency
1 Location available
- T-cell Depleted Alternative Donor Transplantation
Conditions: Acute Lymphoblastic Leukemia - Acute Myeloid Leukemia - Chronic Myeloid Leukemia - Myelodysplastic Syndrome - Lymphomas - Bone Marrow Failure - Hemoglobinopathy - Immune Deficiency - Osteopetrosis
1 Location available
- Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherap
Conditions: Aplastic Anemia - Leukemia - Myelodysplastic Syndrome
1 Location available
- A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies
Conditions: Acute Leukemia - Acute Myeloid Leukemia - Acute Lymphoblastic Leukemia - Biphenotypic Leukemia - Pre-leukemic Syndromes - Monosomy 7 - Bone Marrow Clonal Malformations - Juvenile Myelomonocytic Leukemia - Myelodysplastic Syndromes - Chronic Myelogenous Le
1 Location available
- 5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Conditions: Leukemia
1 Location available
- A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation
Conditions: Acute Lymphoblastic Leukemia - Acute Myeloid Leukemia - Chronic Myeloid Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia
Conditions: Hematopoietic/Lymphoid Cancer - Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Myelodysplastic Syndromes - Recurrent Adult Acute Myeloid Leukemia - Secondary Myelodysplastic Syndromes - Untreated Adult Acute Myeloid Leukemia
2 Locations available
- Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Ad
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) - Adult Acute Myeloid Leukemia With t(16;16)
3 Locations available
- Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS
Conditions: Myelodysplastic Syndrome - MDS
2 Locations available
- Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Nonmalignant Neoplasm
1 Location available
- TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD
Conditions: Myeloproliferative Disorders - Blood Cancer - Myelodysplastic Syndromes
1 Location available
- Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes
1 Location available
- Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Do
Conditions: Leukemia - Myelodysplastic Syndromes
1 Location available
- Fludarabine, Busulfan, and Alemtuzumab Followed By Donor Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Precancerous Condition
2 Locations available
- Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Pa
1 Location available
- T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
Conditions: Acute Myelogenous Leukemia - Lymphoid Leukemia - Chronic Myelogenous Leukemia - Malignant Lymphoma - Hodgkin's Disease - Chronic Lymphocytic Leukemia - Myeloproliferative Disorder - Anemia, Aplastic - Myelodysplastic Syndromes
1 Location available
- Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.
Conditions: Leukemia - Myelodysplastic Syndrome - Non-Hodgkins Lymphoma - Chronic Myelogenous Leukemia
1 Location available
- Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Un
4 Locations available
- A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Prima
Conditions: Acute Myelogenous Leukemia - Myelodysplastic Syndrome
1 Location available
- Studying Fentanyl in Patients With Cancer
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Pr
1 Location available
- MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Conditions: Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Myelodysplastic Syndrome
5 Locations available
- Donor Stem Cell Transplant After Total-Body Irradiation in Treating Patients With Relapsed or Refractory Hematologic Cancer or Acute Myeloid Leukemia
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Does Maitake Mushroom Extract Enhance Hematopoiesis in Myelodysplastic Patients?
Conditions: Myelodysplastic Syndrome
1 Location available
- Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
1 Location available
- Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents
Conditions: Myelodysplastic Syndromes
1 Location available
- Unrelated Donor Stem Cell Transplantation
Conditions: Severe Aplastic Anemia - Paroxysmal Nocturnal Hemoglobinuria - Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Myelodysplastic Syndromes - Myeloproliferative Syndromes - Chronic Myelogenous Leukemia - Hodgkin's Lymphoma - Non-Hodgkin's Lymphom
1 Location available
- Bendamustine Hydrochloride and Idarubicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) - Adult Acute Myeloid Leukemia With t(16;16)
1 Location available
- Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors
Conditions: Leukemia, Myeloid, Acute - Myelodysplastic Syndromes - Lymphoma, Non-Hodgkin - Hodgkin Disease - Leukemia, Lymphocytic, Chronic, B-Cell - Multiple Myeloma
1 Location available
- AHN-12 Biodistribution in Advanced Leukemia
Conditions: Acute Myelogenous Leukemia - Myelodysplastic Syndrome - Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia
1 Location available
- Study of KB004 in Subjects With Hematologic Malignancies
Conditions: Acute Myeloid Leukemia (AML) - Acute Lymphocytic Leukemia (ALL) - Chronic Myelogenous Leukemia (CML) - Myelodysplastic Syndrome (MDS) - Myeloproliferative Neoplasms (MPN)
2 Locations available
- Sirolimus, Cyclosporine, and Mycophenolate Mofetil In Preventing Graft-Versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoi
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder - Adult Acute Lymphoblastic Leukemia in Remission - Adult
2 Locations available
- Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
Conditions: Leukemia
1 Location available
- TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
Conditions: Double Cord Blood Transplant - Acute Myelogenous Leukemia - Myelodysplastic Syndrome - Myelofibrosis - Acute Lymphoblastic Leukemia - Chronic Myelocytic Leukemia - Non Hodgkins Lymphoma - Hodgkins Lymphoma - Chronic Lymphocytic Leukemia
1 Location available
- Monitoring Minimal Residual Disease Following Treatment of Patients With Acute Myeloid Leukemia (AML) or High Grade Myelodysplastic Syndrome (MDS)
Conditions: Acute Myeloid Leukemia - High Grade Myelodysplastic Syndrome
3 Locations available
- Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation
Conditions: Acute Lymphocytic Leukemia - Acute Myelogenous Leukemia - Myelodysplastic Syndrome RAEB 1
2 Locations available
- Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS)
Conditions: Leukemia - Myeloproliferative Diseases
1 Location available
- High-Tc Susceptometer to Monitor Transfusional Iron Overload
Conditions: Transfusional Iron Overload - Thalassemia Major - Sickle Cell Disease - Myelodysplastic Syndromes - Aplastic Anemia
1 Location available
- Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndrome
1 Location available
- PRO#1278: Fludarabin and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation
Conditions: Myeloid Malignancies - Acute Myelogenous Leukemia - Chronic Myelogenous Leukemia - Myeloproliferative Disorders - Myelodysplastic Syndrome
1 Location available
- A Trial of Lenalidomide & Azacitidine in Low Risk Myelodysplastic Syndromes
Conditions: Low and Intermediate 1 Risk MDS
1 Location available
- Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic
Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) - Adult A
1 Location available
- Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Mye
Conditions: Acute Myelogenous Leukemia - Myelodysplastic Syndrome
1 Location available
- Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies
Conditions: Acute Lymphoblastic Leukemia (ALL) - Acute Myelogenous Leukemia (AML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma - Hodgkin's Disease
2 Locations available
- Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transpl
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormali
5 Locations available
- Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Conditions: Myelodysplastic Syndromes - MDS - RAEB - Chronic Myelomonocytic Leukemia
39 Locations available
- Bioequivalence Trial of Luitpold Azacitidine Versus Vidaza® in Patients With Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chro
Conditions: Myelodysplastic Syndrome - Myelofibrosis - Chronic Myeloid Leukemia - Chronic Lymphocytic Leukemia
1 Location available
- Reduced Intensity Conditioning Versus Myeloablative Conditioning for Acute Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)
Conditions: Leukemia, Myelocytic, Acute
28 Locations available
- A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Conditions: Hematologic Malignancies - Acute Leukemia - Myelodysplastic Syndrome (MDS) - Specific Subtypes of Refractory Anemia (RA) or Refractory Anemia With Ringed Sideroblasts(RARS) Subtypes - Myeloproliferative Disorder (MPD) - Hodgkin's Lymphoma - Non-Hodgkin's
1 Location available
- A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Conditions: Thrombocytopaenia
1 Location available
- Administration of Donor T Cells With the Caspase-9 Suicide Gene
Conditions: Acute Lymphoblastic Leukemia - Myelodysplastic Syndrome - Acute Myeloid Leukemia - Chronic Myelogenous Leukemia - Non Hodgkin Lymphoma - Hemophagocytic Lymphohistiocytosis - Familial Hemophagocytic Lymphohistiocytosis - Hemophagocytic Syndrome - Epstein B
2 Locations available
- Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine
Conditions: Myelodysplastic Syndromes - Leukemia, Myelomonocytic, Chronic - Leukemia, Myeloid, Acute
6 Locations available
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
22 Locations available
- Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)
Conditions: Leukemia
1 Location available
- Transplants With Unlicensed Preserved Cord Blood
Conditions: Myelodysplastic Syndrome (MDS) - Hematologic Neoplasms - Hematologic Diseases - Severe Aplastic Anemia
1 Location available
- Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Conditions: Leukemia - Lymphoma - Multiple Myeloma - Plasma Cell Neoplasm - Myelodysplastic Syndromes
4 Locations available
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Un
2 Locations available
- Combined Haploidentical-Cord Blood Transplantation for Adults and Children
Conditions: Leukemia - Myelodysplastic Syndrome - Multiple Myeloma - Lymphoma
1 Location available
- Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Conditions: Breast Cancer - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Ovarian Cancer - Testicular Germ Cell Tumor
1 Location available
- Haploidentical Allogeneic Transplant w/Post Transplant Infusion of Regulatory T-cells (BMT Protocol 204)
Conditions: Leukemia - Leukemia Chronic Myelogenous Leukemia (CML) - Blood and Marrow Transplant (BMT) - Myelodysplastic Syndromes (MDS) - Lymphomas: Non-Hodgkin
1 Location available
- A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS
Conditions: Leukemia, Myelogenous, Acute - Myelodysplastic Syndromes
1 Location available
- HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Tr
Conditions: Acute Lymphoblastic Leukemia - Acute Myelogenous Leukemia - Myelodysplastic Syndrome - Multiple Myeloma
1 Location available
- INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Unspecified Childhood Solid Tumor, Protocol Specific
24 Locations available
- Bortezomib and Midostaurin With or Without Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following - Myelodysplastic Syndrome - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With
1 Location available
- A Study of Two Subcutaneous Regimens of SGI-110, a DNA Hypomethylating Agent, in Subjects With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Le
Conditions: MDS - CMML - AML
7 Locations available
- Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia
Conditions: Myelodysplastic Syndrome (MDS) - Thrombocytopenia
1 Location available
- Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Conditions: GVHD - Adult Acute Myeloid Leukemia - Acute Lymphoid Leukemia - Myelodysplastic Syndrome
17 Locations available
- Azacitidine + Lenalidomide Combo in the Elderly Previously Treated Acute Myeloid Leukemia (AML) & High-Risk Myelodysplastic Syndromes (MDS)
Conditions: Leukemia - Acute Myeloid Leukemia (AML) - Myelodysplastic Syndromes (MDS)
1 Location available
- Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or
Conditions: Acute Myeloid Leukemia - Advanced Myelodysplastic Syndrome
1 Location available
- Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Intermediate-1 Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndrome - MDS
1 Location available
- Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
Conditions: Cancer Survivor - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Testicular Germ Cell Tumor
1 Location available
- Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute
1 Location available
- Sirolimus, Tacrolimus, Antithymocyte Globulin, and Rituximab in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancers or Other Dis
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)
Conditions: Leukemia
1 Location available
- Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome
Conditions: Leukemia
1 Location available
- Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide
Conditions: Hodgkin's Lymphoma - Leukemia - Myelodysplastic Syndrome(MDS) - Multiple Myeloma - Non Hodgkin's Lymphoma
1 Location available
- Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndrome - Chronic Lymphocytic Leukemia - Mantle Cell Lymphoma
1 Location available
- Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission
Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Myeloblastic Leukemia Without Maturation (M1) - Adult Acute Myeloid Leukemia in Remission - Ad
1 Location available
- Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
Conditions: Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia - Chronic Lymphocytic Leukemia - Chronic Myelogenous Leukemia - Hodgkins Disease - Non-Hodgkins Lymphoma - Aplastic Anemia - Multiple Myeloma - Myelodysplastic Syndrome
1 Location available
- Improving Blood Stem Cell Collection and Transplant Procedures
Conditions: Myelodysplastic Syndrome (MDS) - Chronic Myelogenous Leukemia - Acute Lymphoblastic Leukemia - CML (Chronic Myelogenous Leukemia - CLL (Chronic Lymphocytic Leukemia) - Acute Myeloid Leukemia (AML)
1 Location available
- A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: Acute Myeloid Leukemia - High-risk Myelodysplastic Syndrome
1 Location available
- Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
Conditions: Leukemia - Acute Myeloid Leukemia - Acute Lymphocytic Leukemia - Chronic Myeloid Leukemia - Chronic Lymphocytic Leukemia - Myeloproliferative Diseases - Non-Hodgkins Lymphoma - Hodgkins Lymphoma - Multiple Myeloma - Myelodysplastic Syndrome
1 Location available
- Post Transplant Donor Lymphocyte Infusion
Conditions: Leukemia, Myeloid, Chronic - Lymphomas - Multiple Myeloma - Myelodysplastic Syndrome - Leukemia, Lymphocytic, Acute - Leukemia, Lymphocytic, Chronic - AML
1 Location available
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficienc
Conditions: Congenital Amegakaryocytic Thrombocytopenia - Leukemia - Myelodysplastic Syndromes - Severe Congenital Neutropenia
2 Locations available
- DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia - Myelodysplastic Syndromes
3 Locations available
- Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
Conditions: Hematologic Malignancies - Acute Myeloid Leukemia - Lymphoid Leukemia - Chronic Myeloid Leukemia - Hodgkin's Disease - Non-Hodgkin's Lymphoma - Myelodysplastic Syndromes
12 Locations available
- Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome
Conditions: Myelodysplastic Syndrome (MDS) - Severe Aplastic Anemia (SAA)
1 Location available
- Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation
Conditions: Leukemia - Myelodysplastic Syndrome
1 Location available
- LBH589 Plus Decitabine for Myelodysplastic Syndromes or Acute Myeloid Leukemia
Conditions: Leukemia, Myeloid, Acute - Myelodysplastic Syndromes
1 Location available
- MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions
Conditions: Myelodysplastic Syndrome (MDS)
1 Location available
- Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
1 Location available
- Trial of High Dose Lenalidomide in Patients With Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Trilineage Dysplasia (AML-TLD)
Conditions: Myelodysplastic Syndrome
1 Location available
- Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease
Conditions: Leukemia - Lymphoma, Non-Hodgkin - Hodgkin Disease - Myelodysplastic Syndromes - Multiple Myeloma
1 Location available
- Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)
Conditions: Myelodysplastic Syndrome
1 Location available
- Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
Conditions: Acute Myeloid Leukemia - Infantile Leukemia (Both AML and ALL) - Myelodysplastic Syndrome - Myelodysplastic/Myeloproliferative Neoplasms - Biphenotypic Leukemia
1 Location available
- Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndromes
2 Locations available
- Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases
Conditions: Chronic Leukemia - Acute Leukemia - Hodgkin's Disease - Non-Hodgkin's Lymphoma - Myelodysplastic Syndrome
1 Location available
- Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia - Myelodysplastic Syndrome
1 Location available
- Post T-plant Infusion of Allogeneic Cytokine Induced Killer Cells as Consolidate Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders
Conditions: Neural Tube Defects - Anemia - Leukemia, Myeloid - Bone Marrow Transplant Failure - Myelodysplastic Syndromes (MDS) - Myeloproliferative Disorders
1 Location available
- Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndrome (MDS)
1 Location available
- Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hemato
Conditions: Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia - Myelodysplastic Syndrome
1 Location available
- A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndromes
1 Location available
- Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrom
Conditions: Atypical Chronic Myeloid Leukemia, BCR-ABL Negative - Childhood Myelodysplastic Syndromes - Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Essential Thrombocythemia - Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable - Phi
2 Locations available
- Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Myelodysplastic Syndromes - Secondary Myelofibrosis
1 Location available
- ABT-888 and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggres
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes
1 Location available
- Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
Conditions: Leukemia, Myeloid, Acute - Leukemia, Lymphocytic, Acute, T-Cell - Juvenile Myelomonocytic Leukemia Lymphoblastic - T-cell Lymphoblastic Lymphoma - Myelodysplastic Syndrome
1 Location available
- Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
Conditions: Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - Juvenile Myelomonocytic Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)
Conditions: Leukemia
1 Location available
- Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD
Conditions: Graft Versus Host Disease - Leukemia - Myelodysplastic Syndromes
2 Locations available
- Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Conditions: Leukemia
1 Location available
- Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndrome
1 Location available
- SCRI TISSUE TESTING REGISTRY
Conditions: Melanoma - Myelodysplastic Syndrome - Multiple Myeloma - Lymphoma
1 Location available
- Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant
Conditions: Leukemia, Myeloid, Acute - Myelodysplastic Syndromes
1 Location available
- Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndromes
1 Location available
- Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias
Conditions: Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - High-risk Myelodysplastic Syndrome - Chronic Lymphocytic Leukemia - Advanced Myelofibrosis
1 Location available
- Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Ris
Conditions: Leukemia - Myelodysplastic Syndromes
15 Locations available
- Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Sele
Conditions: Severe Aplastic Anemia - MDS (Myelodysplastic Syndrome)
1 Location available
- Nonmyeloablative Allogeneic Transplant
Conditions: Aplastic Anemia - Paroxysmal Nocturnal Hemoglobinuria - Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia - Myelodysplastic Syndrome - Chronic Myelogenous Leukemia - Chronic Lymphocytic Leukemia - Hodgkin's Lymphoma - Non-Hodgkin's Lymphoma - Mantle
1 Location available
- A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes
4 Locations available
- NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndrome
1 Location available
- PRO#0118: Decitabine Plus Mini Flu-Bu
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndrome
1 Location available
- Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndrome (MDS)
3 Locations available
- A Study Comparing Siltuximab Plus Best Supportive Care to Placebo Plus Best Supportive Care in Anemic Patients With International Prognostic Scoring S
Conditions: Myelodysplastic Syndrome
1 Location available
|